Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
45
# OF OVERLAPPING
HOLDINGS
SBIO
80
HOLDINGS
64%
ALSO IN XBI
XBI
139
HOLDINGS
34%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
AMICUS THERAPEUTICS INC | 2.8% | 1.5% | 1.5% |
|
MIRUM PHARMACEUTICALS, INC. | 2.8% | 1.3% | 1.3% |
|
CELCUITY INC. | 3.2% | 1.3% | 1.3% |
 |
ALKERMES PLC | 3.1% | 1.3% | 1.3% |
|
TRAVERE THERAPEUTICS, INC. | 2.0% | 1.2% | 1.2% |
SBIO Overweight Relative to XBI
|
CRINETICS PHARMACEUTICALS INC | 3.2% |
|
KYMERA THERAPEUTICS, INC. | 2.8% |
|
TARSUS PHARMACEUTICALS, INC. | 2.1% |
|
APOGEE THERAPEUTICS, INC. | 1.9% |
|
CELCUITY INC. | 1.9% |
|
ALKERMES PLC | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.8% |
|
NUVATION BIO INC CLASS A | 1.8% |
|
EDGEWISE THERAPEUTICS, INC. | 1.7% |
|
CG ONCOLOGY, INC. | 1.6% |
SBIO Underweight Relative to XBI
|
REVOLUTION MEDICINES, INC. | -1.9% |
|
MODERNA, INC. | -1.4% |
|
HALOZYME THERAPEUTICS INC | -1.4% |
|
INCYTE CORP | -1.4% |
|
BIOMARIN PHARMACEUTICAL INC | -1.3% |
|
REGENERON PHARMACEUTICALS | -1.3% |
|
KRYSTAL BIOTECH, INC. | -1.3% |
 |
ROIVANT SCIENCES LTD. | -1.3% |
|
EXELIXIS INC | -1.3% |
|
BRIDGEBIO PHARMA, INC. | -1.3% |